Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor Sparing Regimen in Antiretroviral-Naïve, HIV-infected Patients

NCT00143689 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00143689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor Sparing Regimen in Antiretroviral-Naïve, HIV-infected Patients
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2002
Completion date
February 29, 2008
Enrollment
13 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, mitochondrial toxicity